C
Catalyst Pharmaceuticals D
D
CPRX
21.460
USD
0.02
(0.09%)
مغلق
حجم التداول
25,300
الربح لكل سهم
2
العائد الربحي
-
P/E
14
حجم السوق
2,617,586,762
الأخبار المقالات
العنوان: Catalyst Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).